首页 工具
登录
购物车
AT9283

AT9283

产品编号 T3068   CAS 896466-04-9
别名: J-504568

AT9283 (J-504568) 是一种多靶点激酶抑制剂,抑制多种实体瘤在体内外的生长和存活,有效抑制Aurora A/B,JAK2/3,Abl (T315I),和Flt3,IC50值范围为 1-30 nM。

TargetMol的所有产品和服务仅用于科学研究,不能被用于人体,我们也不向个人提供产品和服务。
AT9283 Chemical Structure
AT9283, CAS 896466-04-9
规格 价格/CNY 货期 数量
1 mg ¥ 396 现货
2 mg ¥ 569 现货
5 mg ¥ 747 现货
10 mg ¥ 1,350 现货
25 mg ¥ 2,490 现货
50 mg ¥ 3,720 现货
100 mg ¥ 5,350 现货
1 mL * 10 mM (in DMSO) ¥ 822 现货
其他形式的 AT9283:
千万补贴 助力科研
BCA蛋白浓度测定试剂盒限时半价
Venetoclax限时半价
产品目录号及名称: AT9283 (T3068)
点击图片重新获取验证码
选择批次  
纯度: 99.98%
纯度: 99.87%
更多批次查询请联系客服
生物活性
化学信息
存储 & 溶解度
参考文献
产品描述 AT9283 (J-504568) is an effective multi-targeted inhibitor of JAK2(IC50=1.2 nM) and JAK3(IC50=1.1 nM), Aurora A, Aurora B and Abl(T315I).
靶点活性 JAK2:1.2 nM, JAK3:1.1 nM
体外活性 携带HCT116人结肠癌移植瘤的小鼠中,AT9283(15-20 mg/kg)能够抑制肿瘤生长.
体内活性 在HCT116细胞中(IC50=30 nM),AT9283抑制Aurora B 激酶活性,产生多倍体表现型,同时抑制集落形成。AT9283还能够显著抑制多种激酶,例如包括Aurora A(IC50=3 nM), Aurora B( IC50=3 nM), JAK3(IC50=1.1 nM), JAK2(IC50=1.2 nM )和 Abl(IC50=4 nM)。
激酶实验 Aurora A and Aurora B Kinase Assays: Assays for Aurora A and B are performed in a DELFIA format. Aurora A enzyme is incubated with AT9283 and 3 μM cross-tide substrate (biotin-CGPKGPGRRGRRRTSSFAEG) in 10 mM MOPS, pH 7, 0.1 mg/mL BSA, 0.001% Brij-35, 0.5% glycerol, 0.2 mM EDTA, 10 mM MgCl2, 0.01% β-mercaptoethanol, 15 μM ATP, and 2.5% DMSO. Aurora B enzyme is incubated with AT9283, 3 μM of the above substrate in 25 mM Tris, pH 8.5, 5 mM MgCl2, 0.1 mg/mL BSA, 0.025% Tween-20, 1 mM DTT, 15 μM ATP, and 2.5% DMSO. Reactions are allowed to proceed for 60 minutes and 45-90 minutes for Aurora A and Aurora B, respectively, before quenching with EDTA. The reaction mixtures are then transferred to a neutravidin-coated plate, and phosphorylated peptide is quantified by means of a phospho-specific antibody and a europium labeled secondary antibody using time-resolved fluorescence (excitation, 337 nm; emission, 620 nm). IC50 values for the control compounds are 92 nM (Aurora A assay) and 17 nM (Aurora B).
细胞实验 HCT 116 cells are cultured in DMEM + 10% FBS + GLUTAMAX I. Black 96-well flat-bottomed (clear) tissue culture treated plates are seeded in 200 μL of medium and incubated for approximately 16 hours at 37°C in a humidified atmosphere of 5% CO2 in air. Cells are treated with test compound at nine different concentrations (spanning 1 nM to 10 μM, plus DMSO vehicle control) and then incubated for 72 hours. Polyploidy morphological observations of the cells are then noted. The concentration of AT9283 required to produce a distinct polyploid phenotype is reported. Cells are seeded at a concentration of 75−100 cells/mL relevant culture media onto 6- or 24-well tissue culture plates and allowed to recover for 16 hours. Test compound (11 concentrations spanning 0.1 nM to 10 μM) or vehicle control (DMSO) is added to duplicate wells to give a final DMSO concentration of 0.1%. Following compound addition, colonies are allowed to grow between 10 and 14 days for optimum discrete colony counting. Colonies are fixed in 2 mL of Carnoys fixative (25% acetic acid, 75% MeOH) and stained in 2 mL of 0.4% w/v crystal violet. The numbers of colonies in each well is counted. IC50 values are calculated by sigmoidal dose-response (variable slope) IC50 curves using Prism Graphpad software. (Only for Reference)
别名 J-504568
分子量 381.43
分子式 C19H23N7O2
CAS No. 896466-04-9

存储

Powder: -20°C for 3 years | In solvent: -80°C for 1 year

溶解度

DMSO: 71 mg/mL (186.1 mM)

Ethanol: 22 mg/mL(57.7 mM)

H2O: < 1 mg/mL (insoluble or slightly soluble)

溶液配制表

可选溶剂 浓度 体积 质量 1 mg 5 mg 10 mg 25 mg
DMSO / Ethanol 1 mM 2.6217 mL 13.1086 mL 26.2171 mL 65.5428 mL
5 mM 0.5243 mL 2.6217 mL 5.2434 mL 13.1086 mL
10 mM 0.2622 mL 1.3109 mL 2.6217 mL 6.5543 mL
20 mM 0.1311 mL 0.6554 mL 1.3109 mL 3.2771 mL
50 mM 0.0524 mL 0.2622 mL 0.5243 mL 1.3109 mL
DMSO 100 mM 0.0262 mL 0.1311 mL 0.2622 mL 0.6554 mL

TargetMol Calculator计算器

摩尔浓度计算器
稀释计算器
配液计算器
分子量计算器
=
X
X
X
=
X
=
/
g/mol

输入分子式,点击计算,可计算出产品的分子量。

TargetMol Library Books参考文献

1. Howard S, et al. J Med Chem, 2009, 52(2), 379-388. 2. Qi W, et al. Int J Cancer. 2012, 130(12), 21997-32005. 3. Santo L, et al. Clin Cancer Res. 2011, 17(10), 3259-3271. 4. Hou W, Wang Z Y, Lin J, et al. Induction of differentiation of the acute myeloid leukemia cell line (HL-60) by a securinine dimer[J]. Cell Death Discovery. 2020, 6(1): 1-11.

TargetMol Library Books文献引用

1. Cheng S, Jin P, Li H, et al. Evaluation of CML TKI Induced Cardiovascular Toxicity and Development of Potential Rescue Strategies in a Zebrafish Model. Frontiers in Pharmacology. 2021: 2866. 2. Hou W, Wang Z Y, Lin J, et al. Induction of differentiation of the acute myeloid leukemia cell line (HL-60) by a securinine dimer. Cell Death Discovery. 2020, 6(1): 1-11
INH6 Ganetespib Amuvatinib Glycitein SCFSkp2-IN-2 Taccalonolide A Pitstop 2 Ispinesib

相关化合物库

该产品包含在如下化合物库中:
抗癌临床化合物库 抗癌活性化合物库 酪氨酸激酶分子库 抗癌药物库 药物功能重定位化合物库 抑制剂库 激酶抑制剂库 神经退行性疾病化合物库 抗胰腺癌化合物库 临床期小分子药物库

TargetMol Calculator剂量换算

对于不同动物的给药剂量换算,您也可以参考 更多...

TargetMol Calculator 体内实验配液计算器

请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。

母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。

体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。

第一步:请输入动物实验的基本信息
剂量
mg/kg
每只动物体重
g
给药体积
μL
动物数量
第二步:请输入动物体内配方组成,不同的产品配方组成不同,如有配方需求,可先联系我们提供正确的体内配方。
% DMSO
%
% Tween 80
% ddH2O
计算 重置

技术支持

您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。

Keywords

AT9283 896466-04-9 Angiogenesis Apoptosis Autophagy Cell Cycle/Checkpoint Chromatin/Epigenetic Cytoskeletal Signaling JAK/STAT signaling Stem Cells Tyrosine Kinase/Adaptors FLT Aurora Kinase JAK Bcr-Abl AT-9283 Cluster of differentiation antigen 135 J-504568 Janus kinase inhibit Fms like tyrosine kinase 3 FLT3 J504568 AT 9283 Inhibitor J 504568 CD135 inhibitor

 

TargetMol Loading
陶术
生物
TargetMol®中国区唯一合作伙伴
点击进入陶术生物官网陶术生物
联系我们
400-820-0310

上海市静安区江场三路238号8楼